A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Cardio burns more calories per session, while weight training offers sustained metabolic benefits by building lean muscle.

Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

Lilly said it would report data from another trial for the pill for weight management later in the year. It plans to file for ...

Leading medical experts share breakthrough research on protein's role in weight management. Studies demonstrate optimal ...

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

A diverse range of medical specialists offer unique expertise for obesity treatment. “Endocrinologists, bariatricians, obesity specialists and psychiatrists can prescribe weight loss medication,” ...

Weight loss pills are generally safe when taken under proper medical supervision with awareness of potential side effects.